Connection
Gareth Morgan to Septal Occluder Device
This is a "connection" page, showing publications Gareth Morgan has written about Septal Occluder Device.
|
|
Connection Strength |
|
|
|
|
|
5.074 |
|
|
|
-
Minocha PK, Caputo M, Ramroop R, Morgan GJ. Use of the Occlutech pmVSD Device for Hybrid Closure of a Large Mid-Muscular Ventricular Septal Defect in a Small Infant Born With Hypoplastic Aortic Arch. World J Pediatr Congenit Heart Surg. 2024 01; 15(1):109-111.
Score: 0.847
-
Zablah JE, Morgan GJ. Use of Occlutech? atrial flow regulator in a single ventricle patient: a 3D view of a successful intervention. Eur Heart J Cardiovasc Imaging. 2020 10 01; 21(10):1151.
Score: 0.689
-
McLennan D, Ivy D, Morgan GJ. Transvenous implantation of the Occlutech Atrial Flow Regulator: Preliminary results from swine models. Congenit Heart Dis. 2019 Sep; 14(5):819-831.
Score: 0.634
-
Goreczny S, Bedair R, Bilska K, Morgan G. Retrieving a large embolised atrial septal occluder - hooked? and landed. Kardiol Pol. 2017; 75(3):277.
Score: 0.531
-
Morgan GJ. Occlutech? muscular ventricular septal defect device: the first reported human use. Cardiol Young. 2016 Oct; 26(7):1448-51.
Score: 0.512
-
Smith B, Thomson J, Crossland D, Spence MS, Morgan GJ. UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):581-6.
Score: 0.427
-
Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ. Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension. Cardiol Young. 2013 Oct; 23(5):692-6.
Score: 0.397
-
Morgan G, Lee KJ, Chaturvedi R, Benson L. A biodegradable device (BioSTAR) for atrial septal defect closure in children. Catheter Cardiovasc Interv. 2010 Aug 01; 76(2):241-5.
Score: 0.340
-
Sommer RJ, Love BA, Paolillo JA, Gray RG, Goldstein BH, Morgan GJ, Gillespie MJ. ASSURED clinical study: New GORE? CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2020 06 01; 95(7):1285-1295.
Score: 0.164
-
Goreczny S, Morgan GJ, Dryzek P. Live 3D image overlay for arterial duct closure with Amplatzer Duct Occluder II additional size. Cardiol Young. 2016 Mar; 26(3):605-8.
Score: 0.121
-
Kang SL, Tometzki A, Caputo M, Morgan G, Parry A, Martin R. Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children. Catheter Cardiovasc Interv. 2015 May; 85(6):998-1005.
Score: 0.116
-
Kang SL, Morgan G, Forsey J, Tometzki A, Martin R. Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1102-8.
Score: 0.108
-
Thomson JD, Hildick-Smith D, Clift P, Morgan G, Daniels M, Henderson R, Spence MS, Mahadevan VS, Crossland D, Ormerod O. Patent foramen ovale closure with the Gore septal occluder: initial UK experience. Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):467-73.
Score: 0.106
-
Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A, Martin R. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):615-23.
Score: 0.080
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|